Amar D, Zhang H, Park B, Heerdt PM, Fleisher M, Thaler HT. Inflammation and outcome after general thoracic surgery. European Journal of Cardio-thoracic Surgery 2007;32:431-434.
Are C, Gönen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastasis. Annals of Surgery 2007; 246:295-300.
Asmis TR, Capanu M, Kelsen DP, Shah MA. Systemic chemotherapy does not increase the risk of gastrointestinal perforation. Annals of Oncology 2007;18:2006-2008.
Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. Journal of the American Medical Association 2007; 297:953-961. Erratum in: Journal of the American Medical Association 2007; 298:518.
Bach PB, Silvestri GA, Hanger M, Jett JR. American College of Chest Physicians Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132 (3 Suppl):69S-77S.
Bach PB. CT screening for lung cancer. Cleveland Clinic Journal of Medicine 2007; 74:769-770; author reply 770.
Bach PB. CT screening for lung cancer. New England Journal of Medicine 2007; 356:744; author reply 746-747.
Bagatell R, Gore L, Egorin MJ, Ho R, Heller G, Boucher N, Zuhowski EG, Whitlock JA, Hunger SP, Narendran A, Katzenstein HM, Arceci RJ, Boklan J, Herzog CE, Whitesell L, Ivy SP, Trippett TM. Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study. Clinical Cancer Research 2007:13;1783-1788.
Barbour AP, Rizk NP, Gönen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Annals of Surgery 2007;246:1-8.
Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil SM, Van Zee KJ. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Annals of Surgical Oncology 2007;14:2961-2970.
Basch E, Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher HI, McCabe M, Schrag D. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. Journal of the American Medical Information Association 2007;14:264-268.
Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W. Natural standard resource collaboration, flax and flaxseed oil (linum usitatissimum): a review by the Natural Standard Research Collaboration. Journal of the Society for Integrative Oncology 2007;5:92-105.
Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. Journal of Clinical Oncology 2007;25:5374-5380.
Basch E. Expectations for specialized knowledge in oncology: time to reassess. Nature Clinical Practice Oncology 2007;4:263.
Begg CB, Eng KH, Hummer AJ. Statistical tests for clonality. Biometrics 2007;63:522-530.
Begg CB. Letter to the editor of Biometrics. Biometrics 2007;63:964-965; author reply 965-966.
Begg CB. Targeted therapy in oncology. Clinical Trials 2007;4:162.
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE, Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women's environment, cancer and radiation epidemiology study. Journal of the National Cancer Institute 2007;100:32-40.
Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Research 2007;67:9591-9596.
Bjartell AS, Al-Ahmadie H, Serio AM, Eastham JA, Eggener SE, Fine SW, Udby L, Gerald WL, Vickers AJ, Lilja H, Reuter VE, Scardino PT. Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clinical Cancer Research 2007;13:4130-4138.
Black D, Iasonos A, Ahmed H, Chi DS, Barakat RR, Abu-Rustum NR. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. Gynecologic Oncology 2007;107:66-70.
Bylund C, Gueguen J, Sabee C, Imes R, Li Y, Sanford A. Provider-patient dialogue about internet health information: an exploration of strategies to improve the provider-patient relationship. Patient Education and Counseling 2007;66:346-352.
Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis. Cancer 2007;110:2050-2060.
Capanu M, Presnell B. Misspecification tests for binomial and beta-binomial models. Statistics in Medicine 2007; [Epub ahead of print].
Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. Journal of Clinical Oncology 2007;25:5603-5608.
Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ. Complementary therapies and integrative oncology in lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):340S-354S.
Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells 2007;25:771-778.
Chelliah A, Heydon KH, Zaotis TE, Rettig SL, Dominguez TE, Lin R, Patil S, Feudtner C, St John KH, Bell LM, Coffin SE. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Journal of Pediatric Infectious Diseases 2007; 26:816-820.
Chemaitilly W, Boulad F, Heller G, Kernan N, Small TN, O'Reilly RJ, Sklar CA. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007;40:29-35.
Cheung IY, Feng Y, Vickers A, Gerald W, Cheung NK. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. Journal of Molecular Diagnostics 2007;9:237-241.
Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biology Blood Marrow Transplant 2007;13:1313-1323.
Choi H, Shen R, Chinnaiyan AM, Ghosh D. A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. BMC Bioinformatics 2007;8:364.
Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. British Journal of Haematology 2007;139:224-233.
Correa DD, DeAngelis LM, Shi W, Thaler HT, Lin M, Abrey LE. Cognitive functions in low-grade gliomas: disease and treatment effects. Journal of Neurooncology 2007;81:175-184.
Correa DD, Shi W, Thaler HT, Cheung AM, Deangelis LM, Abrey LE. Longitudinal cognitive follow-up in low grade gliomas. Journal of Neuro-oncology [Epub ahead of print].
Cotignola J, Reva B, Mitra N, Ishill N, Chuai S, Patel A, Shah S, Vanderbeek G, Coit D, Busam K, Halpern A, Houghton A, Sander C, Berwick M, Orlow I. Matrix metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Medical Genetics 2007;8:10.
Cotignola J, Roy P, Patel A, Ishill N, Shah S, Houghton A, Coit D, Halpern A, Busam K, Berwick M, Orlow I. Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression. Journal of Negative Results in Biomedicine 2007;6:9.
Dalal KM, Woo Y, Galanis C, Gönen M, Tang L, Allen P, Dematteo R, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of pancreatic cancer patients by the reverse transcriptase polymerase chain reaction. Journal of Gastrointestinal Surgery [Epub ahead of print].
Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical Cancer Research 2007;13:7053-7058.
DeMatteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer [Epub ahead of print]
DeMatteo RP, Maki RG, Singer S, Gönen M, Brennan MF, Antonescu CR. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Annals of Surgery 2007;245:347-352.
Deng G, Vickers A, Yeung S, Cassileth B. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. Journal of Clinical Oncology 2007;25:5584-5590.
Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecologic Oncology 2007;104:435-442.
Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P. Preoperative characterization of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncology 2007;8:304-310.
Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, Alektiar K, Barakat RR, Abu-Rustum NR. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecologic Oncology 2007;105:321-324.
Downey RJ, Akhurst T, Gönen M, Park B, Rusch V. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer. Journal of Thoracic Cardiovascular Surgery 2007;133:1419-1427.
Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of Oncology 2007;19:86-91.
Dunkel IJ, Thomas CL, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH. A phase II trial of carboplatin for intraocular retinoblastoma. Pediatrics Blood & Cancer 2007;49:643-648.
Eastham JA, Kuroiwa K, Ohori M, Serio AM, Gorbonos A, Maru N, Vickers AJ, Slawin KM, Wheeler TM, Reuter VE, Scardino PT. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology 2007;70:965-969.
Eggener SE, Yossepowitch O, Serio AM, Vickers AJ, Scardino PT, Eastham JA. Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy. Urology 2007;69:1128-1133.
Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG, Singer S. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Annals of Surgery 2007;246:105-113.
Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. Journal of Clinical Oncology 2007;25:5275-5280.
Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, Zenz M, Vickers AJ, Tegenthoff M. Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomized trial. Journal of Headache and Pain 2007;8:306-314.
Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Research 2007;67:5545-5552.
Engel LS, Lan Q, Rothman N. Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiology Biomarkers and Prevention 2007;16:373-376.
Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil SM, Cestaro J, Obens E, Sheinfeld J, Bosl GJ, Motzer RJ. Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors. Investigational New Drugs 2007;25:487-490.
Ferrone CR, Brennan MF, Gönen M, Coit DG, Fong Y, Chung S, Tang L, Klimstra D, Allen PJ. Pancreatic adenocarcinoma: the actual 5-year survivors. Journal of Gastrointestinal Surgery [Epub ahead of print].
Ferrone CR, Tang LH, Tomlinson J, Gönen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? Journal of Clinical Oncology 2007;25:5609-5615.
Fornier MN, Seidman AD, Lake D, D'Andrea G, Bromberg J, Robson M, VanPoznak C, Panageas KS, Atienza M, Norton L, Hudis C. Increased dose-density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10 or 11 day intervals with filgrastim support in women with breast cancer. Clinical Cancer Research 2007;13:223-227.
Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clinical Gastronenterology and Hepatology 2007;5:1154-1159.
Gallagher DJ, Capanu M, Raggio G, Kemeny N. Hepatic arterial infusion (HAI) plus systemic irinotecan (CPT-11) in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Annals of Oncology 2007; 18:1995-1999.
Galsky MD, Iasonos A, Mironov S, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function. Cancer 2007;109:549-555.
Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology 2007;69:255-259.
Galsky MD, Mironov S, Iasonos A, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Investigational New Drugs 2007;25:265-270.
Ghosh P, Gönen M. Bayesian modeling of multivariate average bioequivalence. Statistics in Medicine [Epub ahead of print].
Gilewski TA, Ragupathi G, Dickler M, Powell S, Bhuta S, Panageas K, Koganty RR, Chin-Eng, J, Hudis C, Norton L, Houghton AN, Livingston PO. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clin Cancer Res. 2007; 13(10):2977-85
Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies. Pediatric Blood & Cancer 2007;49:261-265.
Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Annals of Surgery [Epub ahead of print].
Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Annals of Surgical Oncology [Epub ahead of print].
Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clinical Cancer Research 2007;13: 5910-5917.
Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Annals of Surgery 2007;245:88-93.
Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, Jumbelic M, Threatte G, Korets R, Lilja H, de la Roza G. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. Journal of the National Cancer Institute 2007;99: 1484-1489.
Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases. Critical Care Medicine 2007;35:692-699.
Hanley JA, Dendukuri N, Begg CB. Multiple imputation for correcting verification bias by Ofer Harel and Xiao-Hua Zhou. Statistics in Medicine 2006;25:3769-3786. Statistics in Medicine 2007;26:3046-3047; author reply 3047-3045.
Harrison ML, Gore ME, Spriggs D, Kaye S, Iasonos A, Hensley M, Aghajanian C, Venkatraman E, Sabbatini P. Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials. Gynecologic Oncology 2007; 106:469-475.
Hay J, Burkhalter J, Ostroff J, Li Y, Quiles Z, Moadel A. Changes in cancer-related risk perception and smoking across time in newly-diagnosed cancer patients. Journal of Behavioral Medicine 2007;30:131-142.
Heller G, Kattan M, Scher H. Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy. Medical Decision Making 2007;27:380-386.
Heller G, Qin J. Inference on the limiting false discovery rate and the p-value threshold parameter assuming weak dependence between gene expression levels within subject. Statistical Applications in Genetics and Molecular Biology 2007:6:Article 14.
Heller G. Smoothed rank regression with censored data. Journal of American Statistical Association 2007;102:552-559.
Ho AY, Fan G, Atencio DP, Green S, Formenti SC, Haffty BG, Iyengar P, Bernstein JL, Stock RG, Cesaretti JA, Rosenstein BS. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. International Journal of Radiation Oncology, Biology, Physics 2007;69:677-684.
House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gönen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. Journal of Gastrointestinal Surgery [Epub ahead of print].
House MG, Gönen M, Jarnagin WR, D'Angelica M, Dematteo RP, Fong Y, Brennan MF, Allen PJ. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. Journal of Gastrointestinal Surgery [Epub ahead of print].
Hurria A, Lichtman SM, Gardes J, Li D, Limaye S, Patil SM, Zuckerman E, Tew W, Hamlin P, Abou-Alfa GK, Lachs M, Kelly E. Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. Journal of the American Geriatrics Society [Epub ahead of print].
Hurria A, Naeim A, Elkin EB, Limaye S, Grover A, Hudis C, Pearce C, Robson M. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Critical Reviews in Oncology/Hematology 2007;61:255-260.
Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Martin Kast W, Hoos A, for the elispot proficiency panel of the CVC immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the cancer vaccine consortium (CVC/SVI). Cancer Immunology, Immunotherapy [Epub ahead of print].
Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P. CA125 level as a predictor of progression free survival and overall survival in ovarian cancer patients with surgically defined disease status at the end of primary therapy. Gynecologic Oncology 2007;104:176-180.
Kaimal G, Steinberg AG, Ennis S, Harasink SM, Ewing R, Li Y. Parental narratives about genetic testing for hearing loss: a one year follow up study. Journal of Genetic Counseling. 2007;6:775-787.
Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP. Neurologic symptoms in licensed pesticide applicators in the Agricultural Health Study. Human & Experimental Toxicology 2007;26:243-250.
Kissane D, Grabsch B, Clarke D, Smith G, Love A, Bloch S, Snyder R, Li Y. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 2007;16:277-286.
Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. Journal of Clinical Oncology 2007;25:85-90. Erratum in: Journal of Clinical Oncology 2007;25:2149.
Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, Berwick M, for the GEM Study Group. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007;18:295-304.
Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. Journal of Pathology 2007;212:143-151.
Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiology, Biomarkers & Prevention 2007;16:906-911.
Lassmann S, Tang L, Capanu M, Brabletz T, Schöpflin A, Zur Hausen A, Gonen M, Kemeny N, Shia J, Klimstra D, Werner M. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology 2007;133:1831-1839.
Leiser AL, Chi DS, Ishill NM, Tew WP. Carcinosarcoma of the ovary treated with platinum and taxane: the Memorial Sloan-Kettering Cancer Center experience.
Gynecologic Oncology 2007;105:657-661.
Levin TT, Riskind J, Li Y. Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. General Hospital Psychiatry 2007;29:251-256.
Levin TT, Riskind JH, Li Y. Looming cognitive style in a cancer cohort. General Hospital Psychiatry 2007;29:32-38.
Levine D, Park K, Juretzka M, Esch J, Hensley M, Aghajanian C, Lewin S, Konner J, Derosa F, Spriggs D, Iasonos A, Sabbatini P. A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission. Cancer 2007;110:2448-2456.
Li Y, Steinberg A, Bain L, Yaeger D, Bieler A, Ewing R, Kaimal G, Krantz I. Assessing parental attitudes toward genetic testing for childhood hearing loss: before and after genetic consultation. American Journal of Medical Genetics 2007;143:1546-1553.
Lilja H, Ulmert D, Björk T, Becker C, Serio AM, Nilsson JA, Abrahamsson PA, Vickers AJ, Berglund G. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. Journal of Clinical Oncology 2007;25:431-436.
Lilja H, Vickers AJ, Scardino P. Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer. Journal of Clinical Oncology 2007;25:347-348.
Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il'yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy M. GLIOGENE an international consortium to understand familial glioma. Cancer Epidemiology, Biomarkers & Prevention 2007;16:1730-1734.
Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gönen M, Kelsen DP, Brennan MF, Coit DG. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Annals of Surgical Oncology [Epub ahead of print].
McIntyre AR, Drummond RA, Riedel ER, Lipman NS. Automated mouse euthanasia in an individually ventilated caging system: system development and assessment. Journal of the American Association of Laboratory and Animal Science 2007;46:65-73.
McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS 3rd, Sclafani LM. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. Journal of American College of Surgeons [Epub ahead of print].
Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Research 2007;67:7991-7995.
Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, Shah RB. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Modern Pathology 2007;20:538-544.
Miller G, Biernacki P, Kemeny NE, Gönen M, Downey R, Jarnagin WR, D'Angelica M, Fong Y, Blumgart LH, DeMatteo RP. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. Journal of the American College of Surgeons 2007;205:231-238.
Morris MJ, Kelly WK, Slovin S, Ryan C, Eicher C, Heller G, Scher HI. A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer. Journal of Urolgoy 2007;178:2378-2383.
Motzer RJ, Basch E. Targeted drugs for metastatic renal cell carcinoma. Lancet 2007;370:2071-2073.
Olson S, Bandera E, Orlow I. Genetic variants, sex steroid hormone levels, and endometrial cancer: a HuGE review. American Journal of Epidemiology 2007;165:235-245.
Olson S, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC. Allergies, variants in IL4 and IL4Ra genes, and risk of pancreatic cancer. Cancer Detection and Prevention 2007;31:345-351.
O'Malley AS, Pham HH, Schrag D, Wu B, Bach PB. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Medical Care 2007;45: 562-570.
Ong SC, Schoder H, Patel SG, Tabangay-Lim IM, Doddamane I, Gönen M, Shaha AR, Tuttle RM, Shah JP, Larson SM. Accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. Journal of Nuclear Medicine 2007;48:501-507.
Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. Journal of Investigational Dermatology 2007;127:1234-1243.
Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. When your look matters: the effect of assessment schedule on progression-free survival. Journal of the National Cancer Institute 2007;99:428-432.
Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer 2007;110:1338-1344.
Panageas KS, Schrag D, Russell Localio A, Venkatraman ES, Begg CB. Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Statistics in Medicine 2007;26:2017-2035.
Park JO, Gönen M, D'Angelica MI, Dematteo RP, Fong Y, Wuest D, Blumgart LH, Jarnagin WR. Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy: autologous transfusion on hepatectomy outcome. Journal of Gastrointestinal Surgery [Epub ahead of print]
Parks R, Gönen M, Kemeny N, Jarnagin W, D'Angelica M, Dematteo R, Garden OJ, Blumgart LH, Fong Y. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. Journal of American College of Surgeons 2007; 204:753-761.
Patel PH, Kondagunta GV, Schwartz L, Ishill N, Bacik J, Deluca J, Russo P, Motzer RJ.
Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma.
Investigational New Drugs [Epub ahead of print].
Perales MA, Ishill N, Lomazow WA, Weinstock DM, Papadopoulos EB, Dastigir H, Chiu M, Boulad F, Castro-Malaspina HR, Heller G, Jakubowski AA, O'reilly RJ, Small TN, Young JW, Kernan NA. Long-term follow-up of patients treated with daclizumab for steroid -refractory acute graft-versus-host disease. Bone Marrow Transplant 2007;40:481-486.
Pham HH, Schrag D, O'Malley AS, Wu B, Bach PB. Care patterns in medicare and their implications for pay for performance. New England Journal of Medicine 2007;356:1130-1139.
Raj GV, Bach AM, Iasonos A, Korets R, Blitstein J, Hann L, Russo P. Predicting the histology of renal masses using pre-operative doppler ultrasonography. Journal of Urology 2007;177:53-58.
Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. Journal of Urology 2007;177:1283-1286; discussion 1286.
Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, Alpodogan O, van den Brink MR. IFN-gamma and Fas ligand are required for graft versus tumor activity against renal cell carcinoma in the absence of lethal graft versus host disease. Journal of Immunology 2007; 179:1669-1680.
Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O. Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagnostic Cytopathology 2007;35:1-5.
Russo P, Snyder M, Vickers A, Kondagunta V, Motzer R. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. TSW Urology 2007;2:42-52
Sabbatini P, Mooney D, Iasonos A, Thaler H, Aghajanian C, Hensley M, Tew W, Konner J, Spriggs D, Abu-Rustum N, Dupont J. CA-125 patterns in recurrent ovarian cancer treated with carboplatin, liposomal doxorubicin, or topotecan. International Journal of Gynecologic Cancer 2007;17:589-594
Sabbatini PJ, Ragupathi G, Hood C, Aghajanian CA, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu Rustum N, Dansihefsky SJ, Livingston PO. Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clinical Cancer Research 2007;13:4170-41777.
Saltz LB, Lenz HJ, Kindler HL, Hochster HS, Wadler S, Hoff PM, Kemeny NE, Hollywood EM, Gönen M, Quinones M, Morse M, Chen HX. Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: The BOND-2 Study. Journal of Clinical Oncology [Epub ahead of print].
Satagopan JM, Sen S, Churchill GA. Sequential quantitative trait locus mapping in experimental crosses. Statistical Applications Genetic Molecular Biology 2007;6:Article 12. [Epub ahead of print].
Scher H, Warren M, Heller G. The association between measures of progression and survival in castrate-metastatic prostate cancer. Clinical Cancer Research 2007:13;1488-1492.
Schoder H, Gönen M. Screening for Cancer with PET and PET/CT: Potential and limitations. Journal of Nuclear Medicine 2007;48 Suppl:4S-18S.
Secin FP, Jiborn T, Bjartell AS, Fournier G, Salomon L, Abbou CC, Haber GP, Gill IS, Crocitto LE, Nelson RA, Cansino-Alcaide JR, Martínez-Piñeiro L, Cohen MS, Tuerk I, Schulman C, Gianduzzo T, Eden C, Baumgartner R, Smith JA, Entezari K, van Velthoven R, Janetschek G, Serio AM, Vickers AJ, Touijer K, Guillonneau B. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. European Urology [Epub ahead of print].
Secin FP, Koppie TM, Salamanca JI, Bokhari S, Raj GV, Olgac S, Serio A, Vickers AJ, Bochner BH. An evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. International Journal of Urology 2007;14:26-32.
Secin FP, Serio A, Bianco FJ Jr, Karanikolas NT, Kuroiwa K, Vickers A, Touijer K, Guillonneau B. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer. European Urology 2007;51:764-771.
Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP. Human Genome Epidemiology Network; the Network of Investigator Networks: The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007;18:1-8.
Sen S, Satagopan JM, Broman KW, Churchill GA. R/qtlDesign: inbred line cross experimental design. Mammalian Genome 2007;18:87-93.
Shaffer DR, Leversha MA, Danilla DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI. Circulating tumor cell analysis in patients with progressive castration resistant prostate cancer. Clinical Cancer Research 2007:13;2023-2029.
Shukla-Dave A, Hricak H, Moskowitz CS, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology 2007;245:499-506.
Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biology Blood Marrow Transplant 2007:3;235-244.
Sofocleous CT, Nascimento RG, Gönen M, Theodoulou M, Covey AM, Brody LA, Solomon SM, Thornton R, Fong Y, Getrajdman GI, Brown KT. Radiofrequency ablation in the management of liver metastases from breast cancer. American Journal of Roentgenology 2007; 189:883-889.
Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Clinical Cancer Research 2007:13;1775-1782.
Sovak MA, Dupont J, Hensley ML, Ishill N, Gerst S, Abu-Rustum N, Anderson S, Barakat R, Konner J, Poyner E, Sabbatini P, Spriggs DR, Aghajanian C. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. International Journal of Gynecological Cancer 2007;17:197-203.
Steinberg A, Kaimal G, Bain L, Krantz I, Li Y. Parental narratives of genetic testing for children with hearing loss: a qualitative inquiry. American Journal of Medical Genetics 2007;143:1533-1545.
Steinberg A, Kaimal K, Li Y, Ewing R, Soslow L, Lewis K, Krantz I. Parental narratives of genetic testing for hearing loss: audiologic implications for clinical work with children and families. American Journal of Audiology 2007;16:57-67.
Stephan MT, Ponomarev V, Brentjens RJ, Chang AH, Dobrenkov KV, Heller G, Sadelain M.T cell-encoded CD80 and 4-1BBL induce auto-and transcostimulation, resulting in potent tumor rejection. Nature Medicine 2007;13:1440-1449.
Steuber T, Vickers AJ, Haese A, Danø K, Høyer-Hansen G, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy. International Journal of Cancer 2007;120:1499-1504.
Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Danø K, Pettersson K, Eastham JA, Scardino PT, Huland H, Lilja H. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. Clinical Chemistry 2007;53:233-240.
Strong VE, D'Angelica M, Tang L, Prete F, Gönen M, Coit D, Touijer KA, Fong Y, Brennan MF. Laparoscopic adrenalectomy for isolated adrenal metastasis. Annals of Surgical Oncology [Epub ahead of print].
Taylor RA, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Journal of Clinical Oncology 2007;25:869-875.
Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiology, Biomarkers and Prevention 2007;16:991-997.
Thompson EE, Pan L, Ostrovnaya I, Weiss LA, Gern JE, Lemanske RF Jr, Nicolae DL, Ober C. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. Journal of Allergy and Clinical Immunology 2007;119:1423-1429.
Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gönen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. Journal of Clinical Oncology 2007;25:4575-4580.
Touijer K, Kuroiwa K, Eastham JA, Vickers A, Reuter VE, Scardino PT, Guillonneau B. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. European Urology 2007;52:1090-1096.
Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. Journal of Urology [Epub ahead of print].
Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. Journal of Clinical Oncology 2007;25:5121-5127.
Tunis SR, Carino TV, Williams RD 2nd , Bach PB. Federal initiatives to support rapid learning about new technologies. Health Affairs (Millwood) 2007;26:140-149.
Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007;23:657-663.
Vickers A. How should we define patients who are at high risk of death from prostate cancer? Nature Clinical Practice Urology 2007;4:646-647.
Vickers AJ, Ballen V, Scher HI. Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testing. Clinical Cancer Research 2007; 13:972-976.
Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. The surgical learning curve for prostate cancer control after radical prostatectomy. Journal of the National Cancer Institute 2007;99:1171-1177.
Vickers AJ, Elkin EB, Steyerberg E. Net reclassification improvement and decision theory. Statistics in Medicine [Epub ahead of print].
Vickers AJ, Kattan MW, Daniel S. Method for evaluating prediction models that apply the results of randomized trials to individual patients. Trials 2007;8:14.
Vickers AJ, Ulmert D, Serio AM, Björk T, Scardino PT, Eastham JA, Berglund G, Lilja H. The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy. International Journal of Cancer 2007;121:2212-2217.
Vickers AJ. How to improve accrual to clinical trials of symptom control 2: design issues. Journal of the Society for Integrative Oncology 2007;5:61-64.
Vickers AJ. Which botanicals or other unconventional anticancer agents should we take to clinical trial? Journal of the Society for Integrative Oncology 2007;5:125-129.
Vickers AJ. How to improve accrual to clinical trials of symptom control 1: recruitment strategies. Journal of the Society for Integrative Oncology 2007;5:38-42.
Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology [Epub ahead of print].
Wang L, Zhang J, Schwartz LH, Eisenberg H, Ishill NM, Moskowitz CS, Scardino P, Hricak H. Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. American Journal of Roentgenology 2007;188:99-104.
Weinstein H, Bates AT, Spaltro BE, Thaler HT, Steingart RM. Influence of preoperative exercise capacity on length of stay after thoracic cancer surgery. Annals of Thoracic Surgery 2007;84:197-202.
Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biology of Blood and Marrow Transplant 2007;13:615-621.
Wolchok JD, Yuan J, Houghton AN, Gallardo HF, Rasalan TS, Wang J, Zhang Y, Ranganathan R, Chapman PB, Krown SE, Livingston PO, Heywood M, Riviere I, Panageas KS, Terzulli SL, Perales MA. Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma. Molecular Therapy 2007;15:2044-2050.
Yeh JJ, Gönen M, Tomlinson JS, Idrees K, Brennan MF, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. British Journal of Surgery [Epub ahead of print].
Yu J, Cao Q, Mehra R, Laxman B, Yu J, Tomlins SA, Creighton CJ, Dhanasekaran SM, Shen R, Chen G, Morris DS, Marquez VE, Shah RB, Ghosh D, Varambally S, Chinnaiyan AM. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell 2007;12:419-431.
Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. Journal of Immunology 2007;179:5977-5989.
Yuan J, Kendle R, Ireland J, Heller G, Sadelain M, Young JW, Rivere I. Scalable expansion of potent genetically modified human Langerhans cells in a closed system for clinical applications. Journal of Immunotherapy 2007;30:634-643.
Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM. Cost-effectiveness of DNA stool testing to screen for colorectal cancer: Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. Agency for Healthcare Research and Quality-Technology Assessment 2007; Dec 20:1-84.
Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, Eisenberg H, Hricak H. Solid renal cortical tumors: differentiation with CT. Radiology 2007;244:494-504.
Zhang J, Lefkowitz RA, Wang L, Ishill NM, Moskowitz CS, Russo P, Hricak H. Significance of peritumoral vascularity on CT in evaluation of renal cortical tumor. Journal of Computer Assisted Tomography 2007;31:717-723.
Zhang Z, Sun L, Sun J, Finkelstein DM. Regression analysis of failure time data with informative interval censoring. Statistics in Medicine 2007;26:2533-2546.
Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL) amyloidosis is associated with response to high-dose melphalan. Blood [Epub ahead of print].
Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology [Epub ahead of print].
